Page last updated: 2024-09-02

cgp 39551 and racemetirosine

cgp 39551 has been researched along with racemetirosine in 1 studies

Compound Research Comparison

Studies (cgp 39551)	Trials (cgp 39551)	Recent Studies (post-2010) (cgp 39551)	Studies (racemetirosine)	Trials (racemetirosine)	Recent Studies (post-2010) (racemetirosine)
75	0	4	1,165	45	96

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maj, J; Rogóz, Z; Skuza, G	1

Other Studies

1 other study(ies) available for cgp 39551 and racemetirosine

Article	Year
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:1 Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase	1993

Article

Year

Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.

Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:1

Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase

1993